In this thesis, we explored electronically-controlled needle-free jet injection-assisted dermal drug delivery of bleomycin as a novel treatment for keloid scars that could potentially lead to a high skin bioavailability, better patient satisfaction, and, ultimately, in higher clinical effectiveness compared to conventional hypodermic needle injections.